Thank you, #Escimeda (escimeda.cz), for supporting the 6th CCP Phenogenomics Conference 2024! We look forward to visiting your booth and learning more about your innovative solutions as the exclusive representative of Eppendorf in the Czech Republic. #CCPConference

Thank you, Exbio Praha, a.s (exbio.cz), for supporting the 6th CCP Phenogenomics Conference 2024! We look forward to visiting your booth and learning more about your cutting-edge monoclonal antibodies and immunological reagents. #CCPConference

Thank you, Transnetyx (transnetyx.com), for supporting the 6th CCP Phenogenomics Conference 2024! We look forward to visiting your booth and learning more about your automated genotyping services and innovative solutions. #CCPConference

It is with great pleasure that we announce the opening of the 6th CCP Phenogenomics Conference, which was officially inaugurated today by Director Radislav Sedláček #CCPconference

David M. Sabatini, the keynote speaker, is now speaking about the mTOR pathway. #CCP2024 #mTOR #Phenogenomics #CCPconference

Thank you, LifeM (lifem.cz), for supporting the 6th CCP Phenogenomics Conference 2024! We look forward to visiting your booth and learning more about your comprehensive range of laboratory supplies and reagents. #CCPConference

Thank you, CANBERRA_PACKARD (cpce.net), for supporting the 6th CCP Phenogenomics Conference 2024! We appreciate your contribution and look forward to learning more about your advanced radiation detection and measurement solutions. #CCPConference

With the lecture on 'Engineering Mammalian Genomes,' keynote speaker Jef Boeke concludes Session 4 – Non-coding & Therapy, and thus the first day of the 6th CCP Phenogenomics Conference 2024. We look forward to seeing all participants tomorrow. #CCPconference

Thank you, MILabs (milabs.com), for supporting the 6th CCP Phenogenomics Conference 2024! We look forward to learning more about your cutting-edge preclinical imaging systems and innovative solutions. #CCPConference

Day 2 of the 6th CCP Phenogenomics Conference was opened by Martin Jinek with his lecture, “CRISPR Genome Editors: Mechanisms, Engineering and Therapeutic Applications.” Session 5 – Models for Gene Therapy & Genome Editing has started.

Superstar Martin Jinek presented today at IMG ⤵️ Thanks Czech Centre for Phenogenomics for such a packed program!

Final lecture of the 6th CCP Phenogenomics Conference, ‘After the Diagnosis: Gene-Based Therapies and the Road to Treatments,’ by Cathleen Lutz (The Jackson Laboratory) is wrapping up the event. Thanks to all speakers and participants for their contributions!

Open Call for Proposals: Nominate Your Gene or Disease The RD-Factory Program invites proposals for preclinical studies aimed at rare human genetic diseases. This open call seeks contributions from the scientific community, rare disease experts, societies, and patient families

We’ve launched the RD-Factory Program for research into rare genetic diseases. Nominate your gene or disease. Annualy, we select 6 proposals. More information at phenogenomics.cz/preclinical-te…. 🌟 #RDFactory #GeneticResearch #RareDiseases

🚀#INFRAPLUS kick off was a success! 2 great days in Munich filled with lively discussions and concrete plans to expand INFRAFRONTIER’s capabilities in in vivo & in vitro models, preclinical services, and data analysis 🐭🧪. Together, we will tackle global biomedical challenges🌍

Thrilled that Betul Melike Ogan, Augusto Vale, Ana Matilde, and František Špouti attended the Imaging Principles of Life 2024 conference in Hustopeče! Thanks to Czech Bioimaging for the excellent organization and inspiring sessions. Looking forward to next year! #CzechBioimaging

We have just welcomed a new member to our cytometric family! The Novocyte Advanteon will stay with us in the immunolab for a couple of weeks to show us its power before moving to the BSL3 facility! ⁦Czech Centre for Phenogenomics⁩

Thinking about a new disease model 🤔🧬🐀 Apply here ⤵️

The 6th CCP Phenogenomics Conference, held from September 17–18, 2024, in Prague, brought together experts in the field of rare diseases, gene therapy, and experimental models.